Strengthening The Quality And Safety Supervision Of Health And Epidemic Prevention Drugs Study On Management

The problem of drug quality and safety has a great influence on people's life.People need qualified drugs to ensure their health,but we often find fake drugs on the market,which directly threaten the lives of users,the main reason is that in the production activities of pharmaceutical manufacturers,out of the mad pursuit of interests,they completely disregard the safety of citizens,trample the bottom line of morality and ignore the law,and put fake and inferior drugs on the market.Since 2013,our government has carried out a series of reforms,especially the reform of drug safety supervision mechanism,involving many sectors.In 2018,the reform of our government structure has been completed.The General Administration of Food and Drug Administration was merged into the State General Administration of market supervision and administration.Instead of a decentralized regulatory model,it has become a centralized management model,which can improve the quality and law enforcement ability of the regulatory team,enhance the overall regulatory capacity,and at the same time improve the regulatory effectiveness,to a certain extent,it has also saved the cost of supervision for the state,which is conducive to further maintaining the socialist market order,guaranteeing the safety of people's lives and cracking down on illegal acts such as counterfeit and inferior medicines.At the same time,there still exists the phenomenon of weakening the government's decision-making function because of the overlapping of duties and other reasons.Under the current Internet information technology background,the government,as the main body of market supervision,needs to ensure that the drug quality has a whole process of supervision and supervision,so as to ensure the quality of drugs and protect people's life safety.Therefore,in the case of the failure of the internal regulation function of the market economy,only by improving the regulatory mechanism can we effectively enhance the quality and safety of drug production.The case in this paper is the Changchun Changsheng vaccine case,we find that companies not only ignore their own moral bottom line and violate laws and regulations,but also expose the deficiencies of the government's function in the process of supervision.In the course of reviewing Changchun Changsheng problem vaccine,this paper also analyzes the government's supervision behavior,so as to find out the key point of the problem.In the course of handling the whole incident,according to the problems revealed,we found that there were such reasons as the government's supervision methods were not reasonable enough,the quality of the supervisors was not high,the supervision was not strong enough,the supervision was not timely enough,and the information communication mechanism was not smooth,on this basis,the corresponding suggestions and countermeasures are put forward.